Advancing DIEP Flap Surgery: Robotic-Assisted Harvest Reduces Pain and Narcotic Use
Journal of Clinical Medicine · 23.07.2025 · 14 (15) · 5204
DOI: 10.3390/jcm14155204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.07.2025. Verfasst von Chloe V McCreery und 3 weiteren Autor:innen. Beteiligte Einrichtung: John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI 96813, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Robotic deep inferior epigastric artery perforator (DIEP) flap surgery is a technique used for autologous breast reconstruction to maintain the integrity of the rectus abdominis muscle while also utilizing robotic assistance for flap harvest. This study assesses postoperative outcomes of patients undergoing robotic DIEP flap reconstruction through the measurement of postoperative pain, narcotics use, and antiemetic usage.
Methods
A retrospective analysis was performed for patients undergoing robotic DIEP flap breast reconstruction between March 2024 and March 2025. Postoperative pain scores (1–10 scale), narcotics usage (measured in oral morphine equivalents), antiemetic usage, and complications were recorded. Patient outcomes were compared to a control group of 40 patients who had undergone abdominal-based free flap breast reconstruction.
Results
Overall, 14 patients underwent robotic DIEP flap breast reconstruction, representing 24 breasts. The average patient age was 56.5 (range: 30–73). Ten patients underwent bilateral breast reconstruction, and four underwent unilateral breast reconstruction. The average length of stay postoperatively was 4.86 days (±1.23 days), and the return of bowel function occurred in 1.29 days (±0.47 days). No patients experienced an unplanned return to the OR or flap failure. Average pain scores on postoperative day 1 (POD1), 2 (POD2), and 3 (POD3) were 4.0 (±0.6), 3.4 (±0.6), and 2.93 (±0.5), respectively. Average antiemetic usage totalled 1.25 doses (±0.25). Average daily OME use was 27.7 (±5.0) for POD1, 25.96 (±6.3) for POD2, and 21.23 (±7.11) for POD3. This averaged to a total hospital OME use of 74.9 (±15.7) per patient. Patients undergoing robotic DIEP flap reconstruction required a significantly lower narcotics dosage, as well as a lower antiemetic dosage, during the first three days postoperatively compared to the control abdominal free flap group. Average pain scores in the robotic DIEP flap reconstruction patient group were also significantly decreased, specifically in POD2 and POD3.
Conclusions
The robotic DIEP flap offers advantages in autologous breast reconstruction compared to other abdominal free flap reconstructive methods. In this limited retrospective study, the use of the robotic DIEP flap lowers chances of flap failure and complications, while also improving narcotics use, antiemetic use, and postoperative pain.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI 96813, USA.
- Department of Surgery, John A. Burns School of Medicine, University of Hawai'I, Queen's University Tower, 1356 Lusitana Street, 6th Floor, Honolulu, HI 96813, USA.
ORCID-Profile: Chloe V McCreery, Daniel Murariu
Zitieren
APA
McCreery, C. V., Liu, A., Deptula, P., & Murariu, D. (2025). Advancing DIEP Flap Surgery: Robotic-Assisted Harvest Reduces Pain and Narcotic Use. Journal of Clinical Medicine, 14(15), 5204. https://doi.org/10.3390/jcm14155204
Vancouver
McCreery CV, Liu A, Deptula P, Murariu D. Advancing DIEP Flap Surgery: Robotic-Assisted Harvest Reduces Pain and Narcotic Use. Journal of Clinical Medicine. 2025;14(15):5204. doi:10.3390/jcm14155204
BibTeX
@article{McCreery2025,
author = {McCreery, Chloe V and Liu, Amy and Deptula, Peter and Murariu, Daniel},
title = {Advancing DIEP Flap Surgery: Robotic-Assisted Harvest Reduces Pain and Narcotic Use},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {15},
pages = {5204},
doi = {10.3390/jcm14155204}
}
EUVIMED